Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose corticosteroid pulses added to conventional oral corticosteroids in moderate ulcerative colitis flares
2016-001170-15Phase 4Active
- Sponsor
- GETECCU
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone in autoimmune colitis, sponsored by GETECCU. Primary endpoint: Clinical remission. Started Aug 2017; status: active.
02
Drugs
methylprednisolone
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2016-001170-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001170-15.